fda_approval · anda · info
SCIEGEN PHARMS — ANDA approval: TOFACITINIB CITRATE (unspecified)
- Event date
- 2026-06-25 00:00:00Z
- Observed
- 2026-07-09 22:53:27Z
- Source ID
- ANDA220972-1
- Payload hash
- 7a959b049b41e7d0ce4b6ec1…
Summary
SCIEGEN PHARMS received ANDA approval for TOFACITINIB CITRATE (unspecified) on 2026-06-25. Dosage form: TABLET, EXTENDED RELEASE. Application #: ANDA220972.
Entities
Informational only. Not legal, financial, or medical advice.